NANOSTRUCTURED DRUG MARKET ANALYSIS
Nanostructured Drug Market – Competitive Landscape
The key players operating in the global nanostructured drug market include Nanoviricides Inc., Ablynx NV, Pfizer Inc., Nanotherapeutics Inc., Arrowhead Research Inc., Abraxis Inc., Merck, Bio-Gate AG, and Celgene Corporation. Market players are focused on adopting of strategies such as increasing funding, acquisition, and collaboration to strengthen their product portfolio and to hold dominant position in the market, For instance, in 2016, Pfizer Inc. received bankruptcy-court approval to buy all asserts of Bind Therapeutics a biotechnology company developing targeted and programmable therapeutics (nanomedicine) called ACCURINS.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 